Balchem Corporation to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 9, 2025
Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer focused on health and nutrition markets, has announced its participation in the upcoming H.C. Wainwright 27th Annual Global Investment Conference scheduled for September 9, 2025.
The company will be represented by key executives including Ted Harris (Chairman, President and CEO), Martin Bengtsson (CFO), and Allison Baurichter (Senior Director of Investor Relations).
Balchem Corporation (NASDAQ: BCPC), produttore globale di ingredienti speciali orientato ai mercati della salute e della nutrizione, ha confermato la sua partecipazione al 27° H.C. Wainwright Annual Global Investment Conference programmato per il 9 settembre 2025.
La società sarà rappresentata da dirigenti chiave, tra cui Ted Harris (Presidente, CEO), Martin Bengtsson (CFO) e Allison Baurichter (Senior Director of Investor Relations).
Balchem Corporation (NASDAQ: BCPC), fabricante mundial de ingredientes especializados centrado en los mercados de salud y nutrición, ha anunciado su participación en la 27.ª Conferencia Mundial de Inversión Anual de H.C. Wainwright, programada para el 9 de septiembre de 2025.
La compañía estará representada por altos directivos, entre ellos Ted Harris (Presidente, CEO), Martin Bengtsson (CFO) y Allison Baurichter (Directora Senior de Relaciones con Inversores).
Balchem Corporation (NASDAQ: BCPC), 건강 및 영양 시장에 주력하는 글로벌 특수 원료 제조업체가 H.C. Wainwright 제27회 연례 글로벌 투자 컨퍼런스에 2025년 9월 9일 참가한다고 발표했습니다.
회사는 Ted Harris(회장 겸 대표이사), Martin Bengtsson(재무책임자), Allison Baurichter(투자자관계 수석이사) 등 주요 경영진이 대표로 참석할 예정입니다.
Balchem Corporation (NASDAQ: BCPC), fabricant mondial d'ingrédients spécialisés axé sur les marchés de la santé et de la nutrition, a annoncé sa participation à la 27e conférence annuelle mondiale H.C. Wainwright prévue le 9 septembre 2025.
La société sera représentée par des cadres dirigeants, notamment Ted Harris (Président, CEO), Martin Bengtsson (CFO) et Allison Baurichter (Directrice principale des relations investisseurs).
Balchem Corporation (NASDAQ: BCPC), ein weltweit tätiger Hersteller von Spezialzutaten mit Schwerpunkt auf Gesundheits- und Ernährungsmärkten, kündigt seine Teilnahme an der 27. H.C. Wainwright Annual Global Investment Conference an, die für den 9. September 2025 geplant ist.
Das Unternehmen wird durch führende Vorstandsmitglieder vertreten, darunter Ted Harris (Chairman, President und CEO), Martin Bengtsson (CFO) und Allison Baurichter (Senior Director of Investor Relations).
- None.
- None.
MONTVALE, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will present at the H.C. Wainwright 27th Annual Global Investment Conference on September 9, 2025. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer, and Allison Baurichter, Senior Director Investor Relations will present at the conference.
About Balchem Corporation
Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the finest quality products for a range of industries worldwide. The company reports three business segments: Human Nutrition & Health; Animal Nutrition & Health; and Specialty Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market.
Contact: | Jacqueline Yarmolowicz |
Balchem Corporation (Telephone: 845-326-5600) |
